Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice

• मुख्य लेखकों: Xiaotong Song (लेखक), Luchang Cao (लेखक), Baoyi Ni (लेखक), Jia Wang (लेखक), Xiaoyan Qin (लेखक), Xiaoyue Sun (लेखक), Bowen Xu (लेखक), Xinmiao Wang (लेखक), Jie Li (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic driver in non-small cell lung cancer (NSCLC). Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are widely used in the treatment of lung cancer, especially in the first-line treatment of advanced NS...